Iterum Therapeutics PLC (NAS:ITRM) Stock News, Headlines & Updates
Iterum Therapeutics PLC Stock News from GuruFocus
- 1
Jul 02, 2025
Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Marketwired • 4:00pm
Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | ITRM Stock News
GuruFocus News • 3:47pm
Jun 30, 2025
Iterum Names Christine Coyne as Chief Commercial Officer to Lead ORLYNVAHâ„¢ Launch and Commercial Growth | ITRM Stock News
GuruFocus News • 6:20am
Iterum Names Christine Coyne as Chief Commercial Officer to Lead ORLYNVAHâ„¢ Launch and Commercial Growth
Marketwired • 6:00am
Jun 25, 2025
Iterum Therapeutics (ITRM) Releases Positive Phase 3 Trial Results | ITRM Stock News
GuruFocus News • 6:30am
Iterum Therapeutics Announces Publication of REASSURE Trial in NEJM Evidence | ITRM Stock News
GuruFocus News • 6:21am
Iterum Therapeutics Announces Publication of REASSURE Trial in NEJM Evidence
Marketwired • 6:00am
Jun 11, 2025
Iterum Therapeutics (ITRM) Partners with EVERSANA for U.S. Launch of ORLYNVAH | ITRM Stock News
GuruFocus News • 6:31am
Iterum Therapeutics Announces Partnership for Commercialization Services
Marketwired • 6:00am
May 19, 2025
Iterum Therapeutics (ITRM) Extends $20M Payment Deadline with Pfizer | ITRM Stock News
GuruFocus News • 6:32am
Iterum Therapeutics Announces Extension of Term of Promissory Note | ITRM Stock News
GuruFocus News • 6:20am
Iterum Therapeutics Announces Extension of Term of Promissory Note
Marketwired • 6:00am
May 14, 2025
Iterum Therapeutics PLC (ITRM) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial Stability Amidst Market Challenges
GuruFocus News • 1:08am
Q1 2025 Iterum Therapeutics PLC Earnings Call Transcript
GuruFocus News • 11:07pm
May 13, 2025
Iterum Therapeutics (ITRM) Projects Adequate Funding Until 2026 | ITRM Stock News
GuruFocus News • 6:50am
ITRM Plans Fourth-Quarter Launch for ORLYNVAH in UTI Treatment | ITRM Stock News
GuruFocus News • 6:50am
Iterum Therapeutics Reports First Quarter 2025 Financial Results
Marketwired • 6:00am
May 08, 2025
Iterum Therapeutics (ITRM) Receives Buy Rating from HC Wainwright & Co | ITRM Stock News
GuruFocus News • 6:32am
Iterum Therapeutics (ITRM) Receives Buy Rating from Analyst | ITRM Stock News
GuruFocus News • 5:51am
May 06, 2025
Iterum Therapeutics to Report First Quarter 2025 Financial Results on May 13, 2025
Marketwired • 6:00am
Apr 30, 2025
Iterum Therapeutics Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares
Marketwired • 4:00pm
Apr 29, 2025
Iterum Therapeutics (ITRM) Secures $5 Million in Direct Offering | ITRM Stock News
GuruFocus News • 7:33am
Iterum Therapeutics Announces $5 Million Registered Direct Offering of Ordinary Shares
Marketwired • 7:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news